1型多发性内分泌肿瘤中具有神经内分泌分化的胸腺瘤（世界卫生组织B3型）
Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1.
作者信息
Tomita Masaki, Ichiki Nobuhiko, Ayabe Takanori, Tanaka Hiroyuki, Kataoka Hiroaki, Nakamura Kunihide
机构信息
Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Kiyotake, Miyazaki, Japan.
Section of Oncopathology and Regenerative Biology, Department of Pathology, Faculty of Medicine, University of Miyazaki, Miyazaki,Japan.
出版信息
J Surg Case Rep. 2017 Apr 4;2017(4):rjx071. doi: 10.1093/jscr/rjx071. eCollection 2017 Apr.
Abstract
Thymic epithelial tumors occur in 1-5% of patients with multiple endocrine neoplasia type 1 (MEN 1). Majority of these thymic epithelial tumors are thymic carcinoids and patients with thymoma in MEN 1 is rare. Furthermore, thymoma with neuroendocrine differentiation was also rarely reported. Herein, we report a 68-year-old man having type B3 thymoma with neuroendocrine differentiation in MEN 1 and to the best of our knowledge this is the first such case ever reported.
摘要
胸腺上皮肿瘤发生于1% - 5%的1型多发性内分泌腺瘤病（MEN 1）患者中。这些胸腺上皮肿瘤大多数是胸腺类癌，而MEN 1患者中患胸腺瘤的情况罕见。此外，具有神经内分泌分化的胸腺瘤也鲜有报道。在此，我们报告一名68岁男性，患有MEN 1相关的具有神经内分泌分化的B3型胸腺瘤，据我们所知，这是首例此类病例报道。
相似文献
1
Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1.
J Surg Case Rep. 2017 Apr 4;2017(4):rjx071. doi: 10.1093/jscr/rjx071. eCollection 2017 Apr.
2
Type B3 thymoma with marked neuroendocrine differentiation: Report of a case.
SAGE Open Med Case Rep. 2019 Feb 1;7:2050313X19827749. doi: 10.1177/2050313X19827749. eCollection 2019.
3
[Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Chir Ital. 2002 May-Jun;54(3):351-4.
4
Thymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report.
J Surg Case Rep. 2022 Jul 8;2022(7):rjac290. doi: 10.1093/jscr/rjac290. eCollection 2022 Jul.
5
Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.
Hum Pathol. 2015 Jan;46(1):17-25. doi: 10.1016/j.humpath.2014.10.001. Epub 2014 Oct 14.
6
Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma.
Pathol Res Pract. 2016 Nov;212(11):1048-1051. doi: 10.1016/j.prp.2016.09.005. Epub 2016 Sep 13.
7
Intrathyroidal thymic carcinoma exhibiting neuroendocrine differentiation: Case report with cytomorphology, immunocytochemistry, and review of the literature focusing on cytology.
Diagn Cytopathol. 2019 Nov;47(11):1197-1202. doi: 10.1002/dc.24281. Epub 2019 Jul 18.
8
[Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
Zhonghua Bing Li Xue Za Zhi. 2011 Dec;40(12):820-4.
9
Pathologic Finding of Thymic Carcinoma Accompanied by Myasthenia Gravis.
J Clin Neurol. 2015 Oct;11(4):372-5. doi: 10.3988/jcn.2015.11.4.372. Epub 2015 Aug 21.
10
[Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):249-54.
引用本文的文献
1
A Novel and Rare Pathogenic Gene Variant in 2 Patients With Multiple Endocrine Neoplasia Type 1 (MEN-1) Syndrome.
JCEM Case Rep. 2025 Feb 4;3(2):luaf003. doi: 10.1210/jcemcr/luaf003. eCollection 2025 Feb.
2
Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review.
Endocrine. 2023 Nov;82(2):442-449. doi: 10.1007/s12020-023-03440-5. Epub 2023 Sep 5.
3
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009.
4
Thymoma (World Health Organization Type AB) in multiple endocrine neoplasia type 1: a case report.
J Surg Case Rep. 2022 Jul 8;2022(7):rjac290. doi: 10.1093/jscr/rjac290. eCollection 2022 Jul.
5
Type B3 thymoma with marked neuroendocrine differentiation: Report of a case.
SAGE Open Med Case Rep. 2019 Feb 1;7:2050313X19827749. doi: 10.1177/2050313X19827749. eCollection 2019.
本文引用的文献
1
Atypical thymoma (World Health Organization Type B3) with neuroendocrine differentiation combined with hyperparathyroidism.
J Thorac Oncol. 2010 Sep;5(9):1490-1. doi: 10.1097/JTO.0b013e3181e04416.
2
Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients.
World J Surg. 2010 Feb;34(2):249-55. doi: 10.1007/s00268-009-0290-1.
3
Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: case report and review.
Endocr Pract. 2008 Sep;14(6):713-6. doi: 10.4158/EP.14.6.713.
4
Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case.
Virchows Arch. 2006 Aug;449(2):234-7. doi: 10.1007/s00428-006-0218-1. Epub 2006 May 4.
5
Resected invasive thymoma with multiple endocrine neoplasia type 1.
Jpn J Thorac Cardiovasc Surg. 2006 Apr;54(4):171-3. doi: 10.1007/BF02662474.
6
Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
J Intern Med. 2006 Apr;259(4):428-32. doi: 10.1111/j.1365-2796.2006.01619.x.
7
Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndrome.
Tumori. 2001 Jul-Aug;87(4):266-8. doi: 10.1177/030089160108700411.
8
Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.
Histopathology. 2000 Jul;37(1):19-26. doi: 10.1046/j.1365-2559.2000.00935.x.
9
Multiple endocrine neoplasia type 1: clinical and genetic topics.
Ann Intern Med. 1998 Sep 15;129(6):484-94. doi: 10.7326/0003-4819-129-6-199809150-00011.
10
Clinicopathologic studies of thymic carcinoids in multiple endocrine neoplasia type 1.
Medicine (Baltimore). 1997 Jan;76(1):21-9. doi: 10.1097/00005792-199701000-00002.
Zotero 插件